EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen

Lurong Huang, Ye Lu, Yanhui Chen, Hongli Liu, Jian An iD

International Journal of Women's Health · 2025-09 · Volume 17 · 3189-3199

DOI: 10.2147/ijwh.s531872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Women's Health, 2025-09. Verfasst von Lurong Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 3610…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is a prevalent malignancy in women that often requires endocrine treatment, such as tamoxifen, which is known to affect endometrial thickness and pose risks of endometrial pathologies.

Objective

This study aimed to determine a clinically relevant threshold for transvaginal ultrasound-measured endometrial thickness in breast cancer patients receiving tamoxifen therapy and assess its predictive value for endometrial pathologies.

Methods

We analyzed a total of 205 endometrial biopsies from women dichotomized into premenopausal and postmenopausal groups. We assessed the clinical and pathological characteristics in relation to the presence of endometrial pathologies, employing receiver operating characteristic (ROC) curves to evaluate the predictive value of endometrial thickness as a diagnostic marker.

Results

Among the study cohort, 11.71% of patients were diagnosed with endometrial hyperplasia, and 3.90% had endometrial cancer. Our findings indicate that women with endometrial pathologies exhibited significantly greater endometrial thickness (P

Schlagwörter

Stichwörter der Autor:innen

breast cancercutoffendometrial pathologyendometriummenopause

Autor:innen und Institutionen

  • Department of Gynecology, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, 361000, People's Republic of China.

ORCID-Profile: Jian An

Zitieren

APA

Huang, L., Lu, Y., Chen, Y., Liu, H., & An, J. (2025). Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen. International Journal of Women's Health, Volume 17, 3189-3199. https://doi.org/10.2147/ijwh.s531872

Vancouver

Huang L, Lu Y, Chen Y, Liu H, An J. Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen. International Journal of Women's Health. 2025;Volume 17:3189-3199. doi:10.2147/ijwh.s531872

BibTeX
@article{Huang2025,
  author = {Huang, Lurong and Lu, Ye and Chen, Yanhui and Liu, Hongli and An, Jian},
  title = {Determining a Treatment Threshold Value for Endometrial Thickness in Women with Breast Cancer Receiving Tamoxifen},
  journal = {International Journal of Women's Health},
  year = {2025},
  volume = {Volume 17},
  pages = {3189--3199},
  doi = {10.2147/ijwh.s531872}
}
Kostenlos starten →